ホームMCPワークベンチSkills
ホームワークベンチ通知マイページ
化工社オープンプロジェクト:[email protected]AIアクセス:llms.txt · MCPガイドプライバシーポリシー · 利用規約 · サポートv1.7.8
  1. ホーム
  2. /化合物

N-[1-(5-シアノペンチルカルバモイル)-1H-ベンゾイミダゾール-2-イル]カルバミド酸メチル

Cypendazole

HCID 34280
ノート反応
基本情報概要名称と識別子物性安全と法規制化学と産業関連反応化合物ノート
部分構造検索類似構造を探す

基本情報

CAS
28559-00-4
標準SMILES
COC(=O)Nc1nc2ccccc2n1C(=O)NCCCCCC#N
InChIKey
MKZGVGOBXZJKGV-UHFFFAOYSA-N
分子式
C16H19N5O3
平均分子量
329.35 g/mol
単同位体質量
329.14878949

概要

Cypendazole is a benzimidazole fungicide and a benzimidazolylcarbamate fungicide.

名称と識別子

優先名称
Cypendazole
IUPAC
methyl N-[1-(5-cyanopentylcarbamoyl)benzimidazol-2-yl]carbamate
現地名
N-[1-(5-シアノペンチルカルバモイル)-1H-ベンゾイミダゾール-2-イル]カルバミド酸メチル
英語名
methyl [1-[[(5-cyanopentyl)amino]carbonyl]-1H-benzimidazol-2-yl]carbamate
分子式
C16H19N5O3
分子量
329.35

名称と別名

CypendazoleCypendazol28559-00-4SL67GU815EBAY-6233Methyl 1-(5-cyanopentylcarbamoyl)benzimidazol-2-ylcarbamateDAM-18654DTXSID3041825BAY-6233ACarbamic acid, (1-(((5-cyanopentyl)amino)carbonyl)-1H-benzimidazol-2-yl)-, methyl esterRefChem:1082801DTXCID1021825
名称をさらに表示
シペンダゾール[1-[(5-シアノペンチル)アミノカルボニル]-1H-ベンゾイミダゾール-2-イル]カルバミン酸メチルホルシジンN-[1-(5-シアノペンチルカルバモイル)-1H-ベンゾイミダゾール-2-イル]カルバミド酸メチル[1-[(5-シアノペンチル)アミノカルボニル]-1H-ベンゾイミダゾール-2-イル]カルバミド酸メチルN-[1-[N-(5-シアノペンチル)カルバモイル]-1H-ベンゾイミダゾール-2-イル]カルバミド酸メチルメチル N-{1-[(5-シアノペンチル)カルバモイル]-1H-1,3-ベンゾジアゾール-2-イル}カルバマートホルサイジンN-[1-(5-Cyanopentylcarbamoyl)-1H-benzimidazol-2-yl]carbamic acid methyl esterCarbamic acid, N-[1-[[(5-cyanopentyl)amino]carbonyl]-1H-benzimidazol-2-yl]-, methyl ester
methyl N-(1-((5-cyanopentyl)carbamoyl)-1H-1,3-benzodiazol-2-yl)carbamate249-082-1Cypendazole [ISO]Methyl (1-(((5-cyanopentyl)amino)carbonyl)-1H-benzimidazol-2-yl)carbamateBAY 6233METHYL [1-[[(5-CYANOPENTYL)AMINO]CARBONYL]-1H-BENZIMIDAZOL-2-YL]CARBAMATEBAY 6233aBAY-DAM 18654

物性

構造計算による物性

XLogP
1.6
極性表面積
109 Ų
水素結合供与体数
2
水素結合受容体数
5
回転可能結合数
7
重原子数
24
形式電荷
0
複雑度
489

物理化学的性質

EPAの化学物質情報
Cypendazole (28559-00-4)

安全と法規制

安全情報は参考情報です。供給元の安全データシート(SDS)、適用法令、専門家による評価に代わるものではありません。

毒性情報

Treatment · 1 件

If the compound has been ingested, rapid gastric lavage should be performed using 5% sodium bicarbonate. For skin contact, the skin should be washed with soap and water. If the compound has entered the eyes, they should be washed with large quantities of isotonic saline or water. In serious cases, atropine and/or pralidoxime should be administered. Anti-cholinergic drugs work to counteract the effects of excess acetylcholine and reactivate AChE. Atropine can be used as an antidote in conjunction with pralidoxime or other pyridinium oximes (such as trimedoxime or obidoxime), though the use of '-oximes' has been found to be of no benefit, or possibly harmful, in at least two meta-analyses. Atropine is a muscarinic antagonist, and thus blocks the action of acetylcholine peripherally.

Health Effects · 1 件

Acute exposure to cholinesterase inhibitors can cause a cholinergic crisis characterized by severe nausea/vomiting, salivation, sweating, bradycardia, hypotension, collapse, and convulsions. Increasing muscle weakness is a possibility and may result in death if respiratory muscles are involved. Accumulation of ACh at motor nerves causes overstimulation of nicotinic expression at the neuromuscular junction. When this occurs symptoms such as muscle weakness, fatigue, muscle cramps, fasciculation, and paralysis can be seen. When there is an accumulation of ACh at autonomic ganglia this causes overstimulation of nicotinic expression in the sympathetic system. Symptoms associated with this are hypertension, and hypoglycemia. Overstimulation of nicotinic acetylcholine receptors in the central nervous system, due to accumulation of ACh, results in anxiety, headache, convulsions, ataxia, depression of respiration and circulation, tremor, general weakness, and potentially coma. When there is expression of muscarinic overstimulation due to excess acetylcholine at muscarinic acetylcholine receptors symptoms of visual disturbances, tightness in chest, wheezing due to bronchoconstriction, increased bronchial secretions, increased salivation, lacrimation, sweating, peristalsis, and urination can occur. Chronically high (>10 years) exposure leads to neuropsychological consequences including disturbances in perception and visuo-motor processing (A15321).

Exposure RoutesInhalation (L793) ; oral (L793); dermal (L793)

化学と産業

薬理情報

Metabolism/Metabolites · 1 件

The carbamates are hydrolyzed enzymatically by the liver; degradation products are excreted by the kidneys and the liver. (L793) Organic nitriles are converted into cyanide ions through the action of cytochrome P450 enzymes in the liver. Cyanide is rapidly absorbed and distributed throughout the body. Cyanide is mainly metabolized into thiocyanate by either rhodanese or 3-mercaptopyruvate sulfur transferase. Cyanide metabolites are excreted in the urine. (L96)

用途と製造

UsesCypendazole is widely used as an insecticide or pesticide in homes, gardens and agricultural applications. It is a synthetic compound.

サプライヤー2 社

上海杰股生物科技有限公司021-51698675 · [email protected]
DAYANG CHEM (HANGZHOU) CO.,LTD+86-88938639 +86-17705817739 · [email protected]

関連反応

0 件
反応記録を作成

現在のフィルター条件では反応記録がありません。

化合物ノート

読み込み中…

このページの内容基本情報概要名称と識別子物性安全と法規制化学と産業関連反応化合物ノート

データベース識別子

CAS
28559-00-4
PubChem CID
34280
DTXSID
DTXSID3041825
ChEBI
CHEBI:82059
UNII
SL67GU815E
EC Number
249-082-1
Nikkaji
J21.577E
Toxicity Summary · 1 件

Cypendazole is a cholinesterase or acetylcholinesterase (AChE) inhibitor. Carbamates form unstable complexes with chlolinesterases by carbamoylation of the active sites of the enzymes. This inhibition is reversible. A cholinesterase inhibitor suppresses the action of acetylcholine esterase. Because of its essential function, chemicals that interfere with the action of acetylcholine esterase are potent neurotoxins, causing excessive salivation and eye-watering in low doses. Headache, salivation, nausea, vomiting, abdominal pain and diarrhea are often prominent at higher levels of exposure. Acetylcholine esterase breaks down the neurotransmitter acetylcholine, which is released at nerve and muscle junctions, in order to allow the muscle or organ to relax. The result of acetylcholine esterase inhibition is that acetylcholine builds up and continues to act so that any nerve impulses are continually transmitted and muscle contractions do not stop.

Signs and Symptoms · 1 件

As with organophosphates, the signs and symptoms are based on excessive cholinergic stimulation. Unlike organophosphate poisoning, carbamate poisonings tend to be of shorter duration because the inhibition of nervous tissue acetylcholinesterase is reversible, and carbamates are more rapidly metabolized. Muscle weakness, dizziness, sweating and slight body discomfort are commonly reported early symptoms. Headache, salivation, nausea, vomiting, abdominal pain and diarrhea are often prominent at higher levels of exposure. Contraction of the pupils with blurred vision, incoordination, muscle twitching and slurred speech have been reported. (L795)

Carcinogen ClassificationNo indication of carcinogenicity to humans (not listed by IARC).